ClearPoint Neuro, Inc. (NASDAQ: CLPT) reported Q2 EPS of ($0.38), $0.09 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $10.9 million versus the consensus estimate of $12.73 million.

For earnings history and earnings-related data on ClearPoint Neuro, Inc. (CLPT) click here.